-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Upgrades Elevance Health to Buy, Announces $510 Price Target

Benzinga·11/18/2026 15:10:00
Listen to the news
Argus Research analyst David Toung upgrades Elevance Health (NYSE:ELV) from Hold to Buy and announces $510 price target.